ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2012

Abstract Number: 1878

Cognitive Manifestations of Fibromyalgia and Lupus

Robert S. Katz and Frank Leavitt, Rush University Medical Center, Chicago, IL

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Cognitive dysfunction, fibromyalgia and systemic lupus erythematosus (SLE)

Session Information

Title: Fibromyalgia and Soft Tissue Disorders

Session Type: Abstract Submissions (ACR)

Background/Purpose: Similar cognitive complaints for patients with fibromyalgia and systemic lupus erythematosus (SLE) have been reported; however, inherently different deficits can share superficial similarities. The major purpose of this study is to determine if the two syndromes have deficits in cognitive functioning in common as measured by the new Mental Clutter Scale.

Methods: The Mental Clutter Scale is a new 16 item scales that focuses on 8 dimensions of the tradition cognitive skills such as memory and concentration, and 8 dimensions of disturbed mental clarity such as cluttered thinking and mental fog.    The measure was administered to 52 patients who met ACR criteria for fibromyalgia and 35 patients who met ACR criteria for Lupus.   The classification criterion for cognitive dysfunction was the upper boundary of the 95% confidence interval (CI) of the normative sample. This score provided prevalence rates of cognitive dysfunction in the two samples.

Results: The two groups were predominantly female (81.5% vs. 82.9%0), with those in the fibromyalgia group significantly older [mean (±SE) age (49.0 ± 12.7 vs. 32.2.3± 10.6 p<0.001)].  Cognitive dysfunction was present in 63.5% (33/52) of the sample with FMS and in 28.6% (10/35) of the sample with Lupus.  The differences were significant (p<0.001).   Both the traditional cognitive symptoms (52.7± 10.0 vs. 32.2± 10.6; p<0.004) and the disturbance in mental clarity (45.5 ± 15.5 vs. 30.6± 10.7; p<0.01) were more pronounced  in fibromyalgia.  Endorsement of the 16 subscales is shown in Table 1.  As can be seen, patients with FMS report significantly higher severity on 5 of 8 cognitive scales, and 7 of 8 mental clarity scales.

Conclusion:   The cognitive findings suggest that there is considerable difference in the cognitive functioning of people with fibromyalgia and Lupus.  The majority of patients with FMS report cognitive dysfunction; whereas only a minority of patients with lupus report cognitive dysfunction.  Among those reporting cognitive dysfunction, cognitive deficits are more pronounced in FMS.  Fog like features as measured by the mental clarity scale are more prominent in fibromyalgia, providing strong support for the notion of fibrofog.  Fog like features play less of a role in lupus, providing weak support for the notion of  brain fog in most lupus patients.



Disclosure:

R. S. Katz,
None;

F. Leavitt,
None.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/cognitive-manifestations-of-fibromyalgia-and-lupus/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology